Herceptin in the Spotlight
A pioneering breast cancer drug may soon be approved for a new use.
By Monica Zangwill, MD

Maneuvering the Maze of Medicare Part D
Newer oral cancer drugs will be covered under the new prescription drug plan.
By Sam Jaffe

Picking Up Momentum for Treating Renal Cell Carcinoma
Advanced treatments take form for a notoriously hard-to-beat cancer.
By Beverly A. Caley

A New Survivors’ Club
Caregivers have a new identity: co-survivor.
By Jennifer Haupt

Message from the Editor
New statistics are promising, but more is needed.
By Vinay Jain, MD

Letters to the Editor

Diagnosis Cancer
Being Positive?
By Kathy LaTour

Finding Hope
Closer to Relief
By Elizabeth Whittington

House Call
What’s the latest in treating pancreatic cancer?
By Henry Q. Xiong, MD, PhD

Moving On
A Mission-Driven Life
By Kathy LaTour

Caregivers’ Corner
The Waiting Room
By Catherine Kanjer Kapphahn

Special Report
Drug Company Questions Marketing of Bioidentical Hormones
By Noble Sprayberry

Readers’ Forum
By Jodi Leas

Bookshelf
By Kathy LaTour

Drugs in the News
By Elizabeth Whittington

People & Places
By Elizabeth Whittington

Toolbox: Resources to Use

Speaking Out
By Diane Blum, CancerCare

Web Exclusive

Food for Thought
Mixing Supplements with
Cancer Therapy
By Christie L. Carter